tiprankstipranks
Trending News
More News >
Omega Healthcare (DE:WX4)
FRANKFURT:WX4
Germany Market

Omega Healthcare (WX4) Ratios

Compare
4 Followers

Omega Healthcare Ratios

DE:WX4's free cash flow for Q4 2025 was $0.47. For the 2025 fiscal year, DE:WX4's free cash flow was decreased by $ and operating cash flow was $0.70. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
3.46 3.46 8.03 7.25 5.30
Quick Ratio
3.46 3.46 8.03 7.25 5.30
Cash Ratio
0.05 0.05 1.58 1.44 0.89
Solvency Ratio
0.20 0.20 0.14 0.10 0.14
Operating Cash Flow Ratio
1.48 1.48 2.28 2.00 1.87
Short-Term Operating Cash Flow Coverage
3.64 3.63 0.00 30.29 32.51
Net Current Asset Value
$ -2.55B$ -2.55B$ -2.53B$ -3.12B$ -3.83B
Leverage Ratios
Debt-to-Assets Ratio
0.42 0.42 0.49 0.56 0.56
Debt-to-Equity Ratio
0.82 0.82 1.07 1.42 1.46
Debt-to-Capital Ratio
0.45 0.45 0.52 0.59 0.59
Long-Term Debt-to-Capital Ratio
0.44 0.44 0.52 0.59 0.59
Financial Leverage Ratio
1.94 1.94 2.18 2.55 2.61
Debt Service Coverage Ratio
2.52 2.50 4.22 3.14 3.95
Interest Coverage Ratio
3.47 3.40 2.98 2.08 1.68
Debt to Market Cap
0.32 0.32 0.50 0.69 0.80
Interest Debt Per Share
15.09 15.12 19.61 22.05 23.36
Net Debt to EBITDA
3.62 3.61 4.56 5.70 4.98
Profitability Margins
Gross Profit Margin
84.91%44.50%98.62%98.42%98.24%
EBIT Margin
70.63%70.51%61.11%51.72%76.22%
EBITDA Margin
97.90%97.65%90.08%85.38%114.07%
Operating Profit Margin
62.59%62.55%62.74%51.48%44.67%
Pretax Profit Margin
52.34%52.10%40.77%26.85%50.49%
Net Profit Margin
49.47%49.25%38.65%25.50%48.61%
Continuous Operations Profit Margin
51.10%50.87%39.74%26.20%49.97%
Net Income Per EBT
94.53%94.54%94.79%94.95%96.28%
EBT Per EBIT
83.61%83.29%64.98%52.16%113.03%
Return on Assets (ROA)
5.87%5.87%4.11%2.66%4.54%
Return on Equity (ROE)
11.83%11.39%8.96%6.78%11.83%
Return on Capital Employed (ROCE)
7.90%7.93%6.89%5.55%4.32%
Return on Invested Capital (ROIC)
7.52%7.55%6.72%5.40%4.27%
Return on Tangible Assets
6.27%6.27%4.39%2.86%4.87%
Earnings Yield
4.45%4.49%4.16%3.28%6.47%
Efficiency Ratios
Receivables Turnover
0.60 0.60 0.52 0.55 0.60
Payables Turnover
0.00 0.00 0.00 0.00 0.00
Inventory Turnover
0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
0.00 0.00 0.00 0.00 0.00
Asset Turnover
0.12 0.12 0.11 0.10 0.09
Working Capital Turnover Ratio
0.61 0.64 0.50 0.56 0.59
Cash Conversion Cycle
611.92 609.17 705.41 662.19 607.84
Days of Sales Outstanding
611.92 609.17 705.41 662.19 607.84
Days of Inventory Outstanding
0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
0.00 0.00 0.00 0.00 0.00
Operating Cycle
611.92 609.17 705.41 662.19 607.84
Cash Flow Ratios
Operating Cash Flow Per Share
2.97 2.97 2.90 2.57 2.65
Free Cash Flow Per Share
2.90 2.97 2.76 2.57 2.45
CapEx Per Share
0.07 0.00 0.15 0.00 0.20
Free Cash Flow to Operating Cash Flow
0.98 1.00 0.95 1.00 0.92
Dividend Paid and CapEx Coverage Ratio
1.10 1.13 1.04 0.96 0.92
Capital Expenditure Coverage Ratio
43.62 0.00 19.85 0.00 13.25
Operating Cash Flow Coverage Ratio
0.21 0.21 0.15 0.12 0.12
Operating Cash Flow to Sales Ratio
0.74 0.73 0.71 0.65 0.71
Free Cash Flow Yield
6.49%6.69%7.29%8.38%8.76%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
22.50 22.25 24.04 30.45 15.47
Price-to-Sales (P/S) Ratio
11.10 10.96 9.29 7.76 7.52
Price-to-Book (P/B) Ratio
2.56 2.53 2.15 2.06 1.83
Price-to-Free Cash Flow (P/FCF) Ratio
15.40 14.94 13.71 11.94 11.41
Price-to-Operating Cash Flow Ratio
15.08 14.94 13.04 11.94 10.55
Price-to-Earnings Growth (PEG) Ratio
2.43 0.78 0.43 -0.72 5.44
Price-to-Fair Value
2.56 2.53 2.15 2.06 1.83
Enterprise Value Multiple
14.96 14.84 14.88 14.80 11.57
Enterprise Value
17.47B 17.36B 14.09B 12.00B 11.59B
EV to EBITDA
14.96 14.84 14.88 14.80 11.57
EV to Sales
14.65 14.49 13.40 12.63 13.20
EV to Free Cash Flow
20.31 19.76 19.77 19.42 20.04
EV to Operating Cash Flow
19.85 19.76 18.80 19.42 18.53
Tangible Book Value Per Share
16.18 16.20 15.83 12.97 13.38
Shareholders’ Equity Per Share
17.48 17.50 17.58 14.86 15.28
Tax and Other Ratios
Effective Tax Rate
0.02 0.02 0.03 0.02 0.01
Revenue Per Share
4.02 4.05 4.07 3.95 3.72
Net Income Per Share
1.99 1.99 1.57 1.01 1.81
Tax Burden
0.95 0.95 0.95 0.95 0.96
Interest Burden
0.74 0.74 0.67 0.52 0.66
Research & Development to Revenue
0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
0.07 0.00 0.08 0.09 0.08
Stock-Based Compensation to Revenue
0.02 0.04 0.03 0.04 0.03
Income Quality
2.07 1.44 1.79 2.48 1.43
Currency in USD